Study: Placenta-derived stem cells are effective for Crohn's disease

10/7/2010 | Detroit News, The

A study presented at the World Stem Cell Summit showed that stem cells derived from a placenta proved effective in improving the condition of patients with Crohn's disease. Celgene Cellular Therapeutics, which is developing the therapy, is working on a Phase II trial of the treatment and is set to start a trial for the treatment in multiple sclerosis patients.

View Full Article in:

Detroit News, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA